JNJ Stock Rises On Fresh FDA Approval For Multiple Myeloma Drug
FDA approved Darzalex Faspro in combination with bortezomib, lenalidomide, and dexamethasone for adults with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplant.
Stocktwits·6d ago
More News
Nike To Reportedly Lay Off 775 Additional Employees
CNBC reported on Monday, citing people familiar with the matter, that the new layoffs will mostly impact distribution center roles in Tennessee and Mississippi
Stocktwits·7d ago
Lululemon Shares Rise On See-Through Leggings Relaunch — New Recommendations Include Skin-Toned Underwear
Earlier this week, Bloomberg reported that Lululemon had removed the ‘Get Low’ collection from its website following customer complaints about their sheerness, merely days after debut.
Stocktwits·11d ago
Lululemon Stock Slips 6% After Reportedly Removing “See-Through” Leggings From Website
The ‘Get Low’ collection has been removed from the firm’s website merely days after its debut, Bloomberg reported.
Stocktwits·13d ago
AMAT Stock Is Breaking Out – Here’s What Changed
Multiple brokerages, including RBC Capital and Barclays, raised the stock’s price target and kept a bullish rating, citing increased spending on semiconductor manufacturing equipment.
Stocktwits·18d ago
Microsoft Unveils Five-Point ‘Community-First AI’ Infrastructure Plan That Includes Capping AI Data Center Costs
Microsoft on Tuesday unveiled a five-point plan that included absorbing power costs, and reducing water usage for its data centers in the U.S.
Stocktwits·20d ago
Lululemon’s US Sales Struggles Are Likely To Extend Into 2026 Despite CEO Reset, Warns UBS
Lululemon’s net revenue from the U.S. region fell 2% in its Q3 earnings due to slowing consumer demand amid macro uncertainties.
Stocktwits·1mo ago
Meta Acquires Singapore-Based Startup To Enhance AI-Capability For Undisclosed Sum
Manus is focused on building a general-purpose AI agent designed to help users tackle research, automation, and complex tasks.
Stocktwits·1mo ago
Lululemon Founder Targets Board Change Ahead Of CEO Search
The proposal seeks to make boardroom revisions before the athletic-apparel company chooses a new CEO
Stocktwits·1mo ago
Why Analysts See Nvidia’s Groq Licensing Deal As A Clear Win For AI Leadership
Despite the reported $20 billion price tag, brokerages believe the deal is small relative to Nvidia's scale and long-term earnings power.